Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

(MENAFN - GlobeNewsWire - Nasdaq) SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS,–Aligos–,–Company–), a clinical stage biopharmaceutical ...